Lucid Inc.

The technology

AMRS is LUCID’s patented Affective Music Recommendation System, a neural reinforcement learning network that predicts and generates playlists to help users achieve their target mood

Why we invested

The shortage of healthcare workers is expected to reach 18 million people by 2030 and will impact all facets of the healthcare system Considering that depression and anxiety are the leading causes of medical disability worldwide and cost global healthcare systems more than US$1 billion per year, the shortage of mental health workers will increase that number to US$16 billion by 2030.
LUCID’s patented AI/ML-based digital music therapy platform offers a scalable and cost-effective solution that could unlock the full therapeutic potential of music as medicine and drive the consumerization of mental health care outside of the clinical setting.